Jérémie Calais, MD, PhD

Christopher Wallis, MD, PhD, FRCSC

GU Oncology Now

<p>J&eacute;r&eacute;mie Calais, MD, PhD, University of California, Los Angeles, and Christopher Wallis, MD, PhD, University of Toronto, discuss a post-hoc analysis assessing the outcomes of 176 patients treated with PSMA PET guided salvage RT, which demonstrated it to be an effective method for treating both pelvic and extrapelvic recurrent prostate cancer.<p><a href="https://guoncologynow.com/category/asco-2023" target="_blank" rel="noopener">View more ASCO 2023 videos</a>.</p></p>


Drs. Calais, Wallis on PSMA PET Guided Salvage Radiotherapy for Prostate Cancer Post-Prostatectomy

American Society of Clinical Oncology 2023 Annual Meeting

ASCO 2023

Drs. Calais and Wallis discuss a post-hoc that demonstrated PSMA PET to be an effective method for treating pelvic, extrapelvic recurrent prostate cancer.

Drs. Calais, Wallis on PSMA PET Guided Salvage RT for PC

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

The Uromigos

Uromigos Live 2024

AUC3

Localized

mHSPC/mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe